ResMed
414 hedge funds and large institutions have $7.57B invested in ResMed in 2017 Q4 according to their latest regulatory filings, with 78 funds opening new positions, 151 increasing their positions, 115 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
414
Holders Change
+53
Holders Change %
+14.68%
% of All Funds
9.4%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.14%
New
78
Increased
151
Reduced
115
Closed
25
Calls
$10.3M
Puts
$5.8M
Net Calls
+$4.55M
Net Calls Change
-$16.8M
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
+$133M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$70.9M |
| 3 |
Renaissance Technologies
New York
|
+$20M |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$19.4M |
| 5 |
JPMorgan Chase & Co
New York
|
+$15M |
Top Sellers
| 1 |
CBOA
Commonwealth Bank of Australia
Sydney, NSW,
Australia
|
-$165M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$45.3M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
-$25.8M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$19.7M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$15.4M |
